Clinical Trial Update: Human Fibrinogen Concentrate (FGTW) in Pediatric Patients With Congenital Fibrinogen Deficiency [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports Phase 2 and Phase 3 studies of human fibrinogen concentrate (FGTW) in pediatric patients with congenital fibrinogen deficienc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Afibrinogenemia
• Congenital Hypofibrinogenemia

Drugs mentioned

• Human Fibrinogen Concentrate (FGTW) (fibrinogen concentrate)

Snippet

Sponsor: Laboratoire français de Fractionnement et de Biotechnologies | Conditions: Hypofibrinogenemia, Congenital, Afibrinogenemia, Congenital | Phase 2, Phase 3 | Status: COMPLETED